AQR Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Sell |
47,516
-1,560
| -3% | -$79.4K | ﹤0.01% | 1670 |
|
|
2025
Q1 | $2.21M | Buy |
49,076
+37,028
| +307% | +$1.67M | ﹤0.01% | 1554 |
|
|
2024
Q4 | $498K | Sell |
12,048
-497
| -4% | -$20.6K | ﹤0.01% | 2252 |
|
|
2024
Q3 | $489K | Buy |
12,545
+4,251
| +51% | +$166K | ﹤0.01% | 2179 |
|
|
2024
Q2 | $284K | Sell |
8,294
-23,721
| -74% | -$811K | ﹤0.01% | 2291 |
|
|
2024
Q1 | $804K | Buy |
32,015
+19,139
| +149% | +$481K | ﹤0.01% | 1784 |
|
|
2023
Q4 | $380K | Sell |
12,876
-2,667
| -17% | -$78.7K | ﹤0.01% | 1990 |
|
|
2023
Q3 | $491K | Buy |
15,543
+3,317
| +27% | +$105K | ﹤0.01% | 1846 |
|
|
2023
Q2 | $316K | Sell |
12,226
-2,320
| -16% | -$60K | ﹤0.01% | 1923 |
|
|
2023
Q1 | $349K | Buy |
14,546
+247
| +2% | +$5.93K | ﹤0.01% | 1898 |
|
|
2022
Q4 | $279K | Buy |
14,299
+3,579
| +33% | +$69.8K | ﹤0.01% | 1996 |
|
|
2022
Q3 | $225K | Buy |
+10,720
| New | +$225K | ﹤0.01% | 2019 |
|